Addition of chemotherapy to nivolumab after PD-1 inhibitor failure as bridge to allogeneic stem cell transplantation in classical Hodgkin’s lymphoma: report on three cases and literature review

The poor prognosis of refractory or relapsed (R/R) classical Hodgkin’s lymphoma (cHL) after autologous stem cell transplantation has improved greatly due to the introduction of brentuximab vedotin and PD-1 inhibitors. However, the duration of response achieved with these novel agents is too short. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Romero, Samuel, Balaguer-Roselló, Aitana, Montoro, Juan, Beneit, Paola, Martínez, Amelia, Ruiz, Cristina, Andreu, Rafael, Guerreiro, Manuel, Arnao, Mario, Montava, Alberto, Vicente, Ana I., Jarque, Isidro, Sanz, Jaime
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381419/
https://www.ncbi.nlm.nih.gov/pubmed/34434538
http://dx.doi.org/10.1177/20406207211038181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381419/
https://www.ncbi.nlm.nih.gov/pubmed/34434538
http://dx.doi.org/10.1177/20406207211038181

Ejemplares similares